Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
As per available reports about 1 open access articles, 5 conferences, 1 national symposiums are presently dedicated exclusively to Trichomoniasis and about 3 speakers gave presentations on Trichomoniasis.
Trichomoniasis is a common cause of vaginitis. It is a sexually transmitted infection, and is caused by the single-celled protozoan parasite Trichomonas vaginalis producing mechanical stress on host cells and then ingesting cell fragments after cell death. Trichomoniasis is the most common curable STD in young, sexually active women. An estimated 7.4 million new cases occur each year in women and men.
OMICS International 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Many people do not have any symptoms. If you do get symptoms, they usually happen within 5 to 28 days after being infected.
Symptoms in women include
• Discomfort during sex
• Vaginal odour
• Painful urination
• Itching in or near the vagina
Men rarely have symptoms. When they do have symptoms, they may have discharge from the urethra the urge to urinate frequently and often with pain and burning. It is easily passed between sex partners. It is spread through vaginal intercourse, sharing sex toys, and mutual masturbation if fluids from one partner are passed to the genitals of the other.
Prevention of Trichomoniasis:
Male condom use:
Using condoms may reduce the risk of becoming infected with an STI. Condoms must be put on before beginning any sexual contact. Use condoms with a new partner until you are certain he or she does not have an STI. It is important that you use a condom properly to prevent the risk of trich infection.
Female condom use:
Even if you are using a birth control method to prevent pregnancy, you may wish to use female condoms to reduce your risk of getting an STI.
According to the Centers for Disease Control and Prevention (CDC), an estimated 3.7 million people in the United States have trichomoniasis. This disease is more common in women and, because only about 30% of those infected develop symptoms of trichomoniasis, most infected persons do not know that they carry the parasite.1 For pregnant women, Trichomonas infection is often associated with preterm delivery and low body weight in newborns. Genital inflammation is often associated with disease and can facilitate infection by other sexually transmitted pathogens, including HIV. Importantly, trichomoniasis can be cured with a single dose of antibiotics, emphasizing the need for rapid, highly sensitive tests that can detect this parasite and prompt immediate treatment.
The AmpliVue Trichomonas Assay is an easy-to-use, self-contained, handheld disposable molecular diagnostic test with superb clinical accuracy and with procedural steps consistent with those commonly seen in moderately complex laboratories. The assay requires no upfront extraction of DNA and generates an accurate result in approximately 50 minutes. Like other previously FDA-cleared AmpliVue assays, the AmpliVue Trichomonas Assay does not require the customer to invest in either expensive thermocycling equipment, or any other upfront testing costs. It is anticipated that minimal training will be required, as is the case with Quidel's other five in vitro diagnostic assays that use the AmpliVue platform. Using AmpliVue can therefore significantly lower a laboratory's cost to adopt and maintain the assay's unique molecular testing methods.
"Our AmpliVue Trichomoniasis Assay has shown excellent performance with samples from both symptomatic and asymptomatic patients. We believe that our test will play a critical role in quickly diagnosing this disease, creating opportunities for patient treatment and thereby limiting its spread," said Douglas Bryant, president and chief executive officer of Quidel Corporation.
This page will be updated regularly.
This page was last updated on 09th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising